blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0524587

EP0524587 - Therapeutic compositions for intranasal administration which include ketorolac TM [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  04.10.1996
Database last updated on 26.03.2025
Most recent event   Tooltip04.10.1996No opposition filed within time limitpublished on 20.11.1996 [1996/47]
Applicant(s)For all designated states
RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY
Corso S. Gottardo 54
6830 Chiasso / CH
[N/P]
Former [1993/04]For all designated states
RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY
Corso S. Gottardo 54
CH-6830 Chiasso / CH
Inventor(s)01 / Santus, Giancarlo
Via Zuara, 8
I-20146 Milan / IT
02 / Bottoni, Giuseppe
Via Don Luigi Guanella, 5
I-24100 Bergamo / IT
03 / Bilato, Ettore
Via S. Mattia, 23
I-35121 Padova / IT
[1993/04]
Representative(s)Gervasi, Gemma, et al
Notarbartolo & Gervasi S.p.A.
Viale Achille Papa, 30
20149 Milano / IT
[N/P]
Former [1993/04]Gervasi, Gemma, Dr., et al
NOTARBARTOLO & GERVASI Srl Viale Bianca Maria 33
I-20122 Milano / IT
Application number, filing date92112394.920.07.1992
[1993/04]
Priority number, dateIT1991MI0202422.07.1991         Original published format: IT MI912024
[1993/04]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0524587
Date:27.01.1993
Language:EN
[1993/04]
Type: B1 Patent specification 
No.:EP0524587
Date:29.11.1995
Language:EN
[1995/48]
Search report(s)(Supplementary) European search report - dispatched on:EP11.11.1992
ClassificationIPC:A61K31/40, A61K9/00
[1993/04]
CPC:
A61K31/40 (EP,US); A61K9/0043 (EP,US); A61P25/04 (EP);
A61P29/00 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1993/04]
TitleGerman:Arzneimittel zur intranasalen Verabreichung, die Ketorolac R enthalten[1993/04]
English:Therapeutic compositions for intranasal administration which include ketorolac TM[1993/04]
French:Compositions thérapeutiques pour l'administration intranasale contenant ketorolac R[1993/04]
Examination procedure22.07.1993Examination requested  [1993/38]
30.09.1993Despatch of a communication from the examining division (Time limit: M04)
02.02.1994Reply to a communication from the examining division
02.12.1994Despatch of communication of intention to grant (Approval: Yes)
04.04.1995Communication of intention to grant the patent
26.06.1995Fee for grant paid
26.06.1995Fee for publishing/printing paid
Opposition(s)30.08.1996No opposition filed within time limit [1996/47]
Fees paidRenewal fee
25.07.1994Renewal fee patent year 03
26.07.1995Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]EP0242643  (DELAWARE CHEMICALS CORP [US]);
 [A]EP0272097  (NOVO INDUSTRI AS [DK]);
 [Y]WO9001322  (UNIV KENTUCKY RES FOUND [US]);
 [Y]US4973596  (COHEN EDWIN A [US])
 [YD]  - DRUG METABOLISM AND DISPOSITION vol. 15, no. 5, 1987, pages 616 - 626; E.J. MROSZCZAK ET AL.: 'Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans'
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.